Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy

Documenti analoghi

• Probability of pharmacokinetic/pharmacodynamic target attainment for different piperacillin/tazobactam dosing regimens in renally impaired patients in a non‐intensive care unit setting
  di: Emma Dohmann, et al.
  Pubblicazione: (2025)
• Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
  di: Shakir Atoyebi, et al.
  Pubblicazione: (2024)
• Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages
  di: Cheng‐jie Ke, et al.
  Pubblicazione: (2025)
• Physiologically based pharmacokinetic modelling of cefoperazone in paediatrics
  di: Qiushi Wang, et al.
  Pubblicazione: (2024)
• Minimal impact of pregnancy on rilpivirine pharmacokinetics: A POPPK approach
  Pubblicazione: (2024)